Molina Healthcare nimmt an UBS Global Healthcare Conference teil

• Molina Healthcare nimmt am 9. November 2026 an der UBS Global Healthcare Conference teil.
• Das Management will die Jahresprognose 2026 bekräftigen: verwässertes GAAP-Ergebnis je Aktie mindestens 2.38 US-Dollar, bereinigt mindestens 5.25 US-Dollar.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Molina Healthcare Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-035576), on November 06, 2026, and is solely responsible for the information contained therein.